A fun, huge leap - and surprisingly useful for real work. After its release last week, I ran ChatGPT Images 2.0 through a series of tests to prov ...

Good morning and welcome to the Weekly New York Health Care newsletter, where we keep you posted on what’s coming up this week in health care news, and offer a look back at the important news from ...

Artemis II has launched, sending a crew of four astronauts on a mission to circle the moon and back to Earth, the first step toward planned lunar landings and eventual habitation on the lunar surface.

Java has endured radical transformations in the technology landscape and many threats to its prominence. What makes this technology so great, and what does the future hold for Java? In a world ...

Michaela Mulligan is a climate and environment reporter. Reach her at [email protected]. Anyone can view a sampling of recent comments, but you must be a Times subscriber to contribute. Log in ...

I test a lot of coffee machines. Like, a lot of them. The Ratio Four is the small-batch brewer I use to try new kinds of coffee. Coffee is the original office biohack and the nation’s most popular ...

New NASA Administrator Jared Isaacman announced a major overhaul of the agency's Artemis moon program Friday, acknowledging that the agency's plan to land astronauts on the moon in 2028 was not ...

A mock-up of the European New Generation Fighter for the Future Combat Air System is pictured at the Paris Air Show, June 18, 2023. (Julien de Rosa/AFP via Getty Images) PARIS — Airbus is open to a ...

AUSTIN – Acting Texas Comptroller Kelly Hancock announced that a record number of students have applied for the Texas Education Freedom Accounts (TEFA) since applications opened on Wednesday. The ...

The Two Rivers community garden program has seen high demand for the 2026 growing season. Nearly all of the 115 garden plots were claimed shortly after applications opened in mid-January. Each 3-by-20 ...

Reviews of Sanofi’s diabetes drug Tzield and Disc Medicine’s blood-disorder medicine bitopertin stalled Tzield pushed back after adverse event reports; bitopertin delayed two weeks amid efficacy and ...